These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 1800077

  • 1. The efficacy of norfloxacin in the treatment of urinary tract infections in Tikure Anbessa Hospital, Addis Ababa, Ethiopia.
    Mengesha B.
    East Afr Med J; 1991 Nov; 68(11):844-52. PubMed ID: 1800077
    [Abstract] [Full Text] [Related]

  • 2. [Clinical evaluation of norfloxacin preparation in treatment of bacterial infections of the urinary tract in patients with various kidney diseases].
    Mazanowska O, Boratyńska M, Mróz E, Starek J.
    Pol Tyg Lek; 1991 Nov; 49(6-7):154-7. PubMed ID: 8090671
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Randomized double-blind trial of high- and low-dose fleroxacin versus norfloxacin for complicated urinary tract infection.
    Pittman W, Moon JO, Hamrick LC, Cox CE, Clark J, Childs S, Pizzuti D, Fredericks J, St Clair P.
    Am J Med; 1993 Mar 22; 94(3A):101S-104S. PubMed ID: 8452163
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Fleroxacin versus norfloxacin for oral treatment of serious urinary tract infections.
    Childs SJ.
    Am J Med; 1993 Mar 22; 94(3A):105S-107S. PubMed ID: 8452164
    [Abstract] [Full Text] [Related]

  • 9. [Clinical experience of norfloxacin in urinary tract infection].
    Banya Y, Funaki H, Takagane H, Tanji S, Abe T, Aoki H, Kubo T, Ohori T.
    Hinyokika Kiyo; 1985 Aug 22; 31(8):1501-17. PubMed ID: 4083210
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Fleroxacin versus norfloxacin in the treatment of urinary tract infections: a multicenter, double-blind, prospective, randomized, comparative study.
    Pummer K.
    Am J Med; 1993 Mar 22; 94(3A):108S-113S. PubMed ID: 8452165
    [Abstract] [Full Text] [Related]

  • 12. Treatment of urinary tract infections in Hong Kong: a comparative study of norfloxacin and co-trimoxazole.
    Wong WT, Chan MK, Li MK, Wong WS, Yin PD, Cheng IK.
    Scand J Infect Dis Suppl; 1988 Mar 22; 56():22-7. PubMed ID: 3074462
    [Abstract] [Full Text] [Related]

  • 13. Norfloxacin versus co-trimoxazole for the treatment of upper urinary tract infections: a double blind trial.
    Tungsanga K, Chongthaleong A, Udomsantisuk N, Petcharabutr OA, Sitprija V, Wong EC.
    Scand J Infect Dis Suppl; 1988 Mar 22; 56():28-34. PubMed ID: 3074463
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Norfloxacin: a three-day course for the treatment of urinary tract infection.
    Ganguli LA, Keaney MG, Gould LJ.
    Drugs Exp Clin Res; 1985 Mar 22; 11(3):177-9. PubMed ID: 3836125
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The use of norfloxacin in a university hospital.
    Alaniz C, Stumpf JL, Townsend KA.
    Hosp Pharm; 1991 Aug 22; 26(8):707-10, 719. PubMed ID: 10112581
    [Abstract] [Full Text] [Related]

  • 18. Efficacy and safety of self-start therapy in women with recurrent urinary tract infections.
    Schaeffer AJ, Stuppy BA.
    J Urol; 1999 Jan 22; 161(1):207-11. PubMed ID: 10037399
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Comparison of short-term treatment regimen of ciprofloxacin versus long-term treatment regimens of trimethoprim/sulfamethoxazole or norfloxacin for uncomplicated lower urinary tract infections: a randomized, multicentre, open-label, prospective study.
    Arredondo-García JL, Figueroa-Damián R, Rosas A, Jáuregui A, Corral M, Costa A, Merlos RM, Ríos-Fabra A, Amábile-Cuevas CF, Hernández-Oliva GM, Olguín J, Cardeñosa-Guerra O, uUTI Latin American Study Group.
    J Antimicrob Chemother; 2004 Oct 22; 54(4):840-3. PubMed ID: 15347634
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.